Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Price/Earnings ttm 16.40
  • Annual Dividend & Yield 0.45 (0.37%)
  • Most Recent Dividend 0.407 on 12/22/25
  • Management Fee 0.35%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 41.24% (+4.39%)
  • Historical Volatility 27.14%
  • IV Percentile 97%
  • IV Rank 55.82%
  • IV High 56.80% on 04/08/25
  • IV Low 21.59% on 07/24/25
  • Expected Move (DTE 5) 4.61 (3.85%)
  • Put/Call Vol Ratio 1.13
  • Today's Volume 76,479
  • Volume Avg (30-Day) 38,546
  • Put/Call OI Ratio 2.35
  • Today's Open Interest 732,098
  • Open Int (30-Day) 780,806
  • Expected Range 114.98 to 124.20

Price Performance

See More
Period Period Low Period High Performance
1-Month
118.19 +1.18%
on 03/24/26
129.11 -7.37%
on 03/10/26
-7.78 (-6.11%)
since 02/27/26
3-Month
118.19 +1.18%
on 03/24/26
132.09 -9.46%
on 01/22/26
-5.39 (-4.31%)
since 12/26/25
52-Week
66.66 +79.40%
on 04/09/25
132.09 -9.46%
on 01/22/26
+34.06 (+39.82%)
since 03/27/25

Most Recent Stories

More News
How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks

Bio-Techne has underperformed other biotechnology stocks over the past year, yet analysts remain moderately optimistic about the stock’s growth potential.

TECH : 50.95 (-3.32%)
BBIO : 69.70 (-3.97%)
XBI : 119.59 (-3.48%)
Do Wall Street Analysts Like Incyte Corporation Stock?

Wall Street is keeping a confident yet pragmatic stance on Incyte Corporation, supported by steady growth and a promising pipeline.

$SPX : 6,368.85 (-1.67%)
INCY : 90.30 (-2.12%)
XBI : 119.59 (-3.48%)
How to Invest in the New Era of Agentic AI for Biotech Stocks

Our senior market strategist explains which ETFs offer exposure to high-powered biotech growth, without T. Rex-sized risk.

ARKG : 25.01 (-5.66%)
IBB : 160.41 (-2.93%)
XBI : 119.59 (-3.48%)
3 Biotech Stocks Wall Street Analysts Predict Will More Than Double

What makes analysts so bullish about these three names from the sector?

MEHCQ : 3.5000 (-2.78%)
GHRS : 13.15 (-6.67%)
TYRA : 36.29 (-4.58%)
DMAC : 6.79 (-0.88%)
XBI : 119.59 (-3.48%)
Biogen Stock: Analyst Estimates & Ratings

Biogen has lagged the broader market over the past year, yet analysts maintain a cautiously optimistic outlook on the stock’s future performance.

$SPX : 6,368.85 (-1.67%)
XBI : 119.59 (-3.48%)
BIIB : 183.84 (-3.78%)
How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?

Incyte has underperformed relative to its biotech peers over the past year, though Wall Street analysts maintain a cautiously optimistic view on the stock’s outlook.

INCY : 90.30 (-2.12%)
EXEL : 41.53 (-1.96%)
XBI : 119.59 (-3.48%)
How Is Vertex Pharmaceuticals’ Stock Performance Compared to Other Biotech Stocks?

Vertex Pharmaceuticals has outperformed its biotech peers over the past year, yet Wall Street analysts maintain a reasonably optimistic outlook on its future potential.

VRTX : 433.07 (-4.56%)
REGN : 737.71 (-2.51%)
XBI : 119.59 (-3.48%)
Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets

Shares of lung cancer-focused biotech Summit Therapeutics (NASDAQ: SMMT) rallied 16.6% at its highs of the day before settling into a 10.4% gain on Thursday as of 3:54 p.m. EDT, even though the broader...

SMMT : 16.58 (-3.94%)
XBI : 119.59 (-3.48%)
Retail Traders Mostly Bullish On Biotech Stocks Amid Blow From RFK Jr. Purge On Health Agencies

The sector's recent slide follows Peter Marks' resignation last week as the Food and Drug Administration's top vaccine regulator following a clash with Kennedy.

TECH : 50.95 (-3.32%)
VRTX : 433.07 (-4.56%)
MRNA : 49.56 (-7.49%)
REGN : 737.71 (-2.51%)
XBI : 119.59 (-3.48%)
Soleno Therapeutics Stock Rockets 34% Pre-Market After FDA Approves Prader-Willi Syndrome Drug: Retail Sentiment Peaks

The company expects the drug, the first approved therapy to address hyperphagia in PWS patients, to be available in the U.S. starting April 2025.

VTI : 313.09 (-1.71%)
SLNO : 30.05 (-5.68%)
XBI : 119.59 (-3.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 126.53
2nd Resistance Point 125.11
1st Resistance Point 122.35
Last Price 119.59
1st Support Level 118.17
2nd Support Level 116.75
3rd Support Level 113.99

See More

52-Week High 132.09
Last Price 119.59
Fibonacci 61.8% 107.10
Fibonacci 50% 99.38
Fibonacci 38.2% 91.65
52-Week Low 66.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.